WO2007092465A3 - Topical delivery compositions - Google Patents
Topical delivery compositions Download PDFInfo
- Publication number
- WO2007092465A3 WO2007092465A3 PCT/US2007/003187 US2007003187W WO2007092465A3 WO 2007092465 A3 WO2007092465 A3 WO 2007092465A3 US 2007003187 W US2007003187 W US 2007003187W WO 2007092465 A3 WO2007092465 A3 WO 2007092465A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- topical delivery
- delivery compositions
- compositions
- topical
- skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention is generally related to products and methods that delivery pharmaceutical agents to the skin.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77105206P | 2006-02-07 | 2006-02-07 | |
US60/771,052 | 2006-02-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007092465A2 WO2007092465A2 (en) | 2007-08-16 |
WO2007092465A3 true WO2007092465A3 (en) | 2008-02-07 |
Family
ID=38345757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/003187 WO2007092465A2 (en) | 2006-02-07 | 2007-02-05 | Topical delivery compositions |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007092465A2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997038728A1 (en) * | 1996-04-15 | 1997-10-23 | Dyad Pharmaceutical Corporation | Combination therapy for androgenic alopecia with antisense oligonucleotides and minoxidil |
WO2005042741A2 (en) * | 2003-10-21 | 2005-05-12 | Dyad Pharmaceutical Corporation | METHODS AND COMPOSITIONS FOR TREATING 5alpha-REDUCTASE TYPE 1 AND TYPE 2 DEPENDENT CONDITIONS |
US20050203026A1 (en) * | 2003-11-06 | 2005-09-15 | Day Anthony G. | Peptides and supported peptides for treating skin diseases |
-
2007
- 2007-02-05 WO PCT/US2007/003187 patent/WO2007092465A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997038728A1 (en) * | 1996-04-15 | 1997-10-23 | Dyad Pharmaceutical Corporation | Combination therapy for androgenic alopecia with antisense oligonucleotides and minoxidil |
WO2005042741A2 (en) * | 2003-10-21 | 2005-05-12 | Dyad Pharmaceutical Corporation | METHODS AND COMPOSITIONS FOR TREATING 5alpha-REDUCTASE TYPE 1 AND TYPE 2 DEPENDENT CONDITIONS |
US20050203026A1 (en) * | 2003-11-06 | 2005-09-15 | Day Anthony G. | Peptides and supported peptides for treating skin diseases |
Also Published As
Publication number | Publication date |
---|---|
WO2007092465A2 (en) | 2007-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008116135A3 (en) | Topical formulations having enhanced bioavailability | |
AU2007299727A8 (en) | Self preserved aqueous pharmaceutical compositions | |
WO2007141392A3 (en) | Compositions comprising betulonic acid | |
EP2045251A4 (en) | Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
WO2010127099A3 (en) | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same | |
WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
WO2006096439A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases | |
EP2813223B8 (en) | Metal delivery agents and therapeutic uses of the same | |
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
WO2010000877A3 (en) | Formulation with irritation reducing action comprising bisabolol and [6]-paradol | |
IL194699A (en) | Tetrahydropteridines, compositions comprising them and use thereof in the preparation of medicaments | |
WO2008070268A3 (en) | Pharmaceutical compositions | |
WO2008076954A3 (en) | Heterocycle compounds and methods of use thereof | |
WO2007125105A3 (en) | Benzamide glucokinase activators | |
JO2721B1 (en) | Artemisinin Derivative Dimers, Their preparation and their therapeutic application | |
WO2011141685A3 (en) | Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof | |
EP2045253A4 (en) | alpha-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT | |
HK1142536A1 (en) | Gel useful for the delivery of cosmetic active ingredients | |
WO2009071689A3 (en) | 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases | |
WO2010021607A3 (en) | Pharmaceutical formulation | |
GB0821730D0 (en) | Assessment of the effects of topical administration of chemodenervating pharmaceuticals | |
WO2010121164A3 (en) | 1,4-benzodiazepinone compounds and their use in treating cancer | |
WO2007067784A3 (en) | Liposomal compositions | |
WO2010092088A3 (en) | Use of hydrophobin as a spreading agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC, EPO FORM 1205A DATED 19.11.2008. |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07763694 Country of ref document: EP Kind code of ref document: A2 |